Estrella Immunopharma
ESLA
ESLA
11 hedge funds and large institutions have $341K invested in Estrella Immunopharma in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$78.2K |
| 2 |
State Street
Boston,
Massachusetts
|
$25.3K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$106K |
| 4 |
TSS
Two Sigma Securities
New York
|
$12.8K |
| 5 |
BlackRock
New York
|
$30.1K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$4.55K |
| 3 |
JPMorgan Chase & Co
New York
|
$29 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $106K | +$19.1K | +16,862 | +22% |
|
|
2
UBS Group
Zurich,
Switzerland
| $78.2K | +$70.4K | +58,644 | +899% |
|
|
ASM
3
ATW SPAC Management
New York
| $48K | – | – | – |
|
|
4
BlackRock
New York
| $30.1K | +$186 | +155 | +0.6% |
|
|
5
State Street
Boston,
Massachusetts
| $25.3K | +$25.3K | +22,352 | New |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $24.5K | – | – | – |
|
|
TSS
7
Two Sigma Securities
New York
| $12.8K | +$12.8K | +10,640 | New |
|
|
MCP
8
Maso Capital Partners
Hong Kong
| $12K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $4.55K | -$2.33K | -1,940 | -34% |
|
10
Bank of America
Charlotte,
North Carolina
| $100 | – | – | – |
|
|
11
JPMorgan Chase & Co
New York
| $29 | -$1 | -1 | -4% |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$16.9K | -14,531 | Closed |
|